Correlation Between Lyra Therapeutics and Psyence Biomedical
Can any of the company-specific risk be diversified away by investing in both Lyra Therapeutics and Psyence Biomedical at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Lyra Therapeutics and Psyence Biomedical into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Lyra Therapeutics and Psyence Biomedical Ltd, you can compare the effects of market volatilities on Lyra Therapeutics and Psyence Biomedical and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Lyra Therapeutics with a short position of Psyence Biomedical. Check out your portfolio center. Please also check ongoing floating volatility patterns of Lyra Therapeutics and Psyence Biomedical.
Diversification Opportunities for Lyra Therapeutics and Psyence Biomedical
0.68 | Correlation Coefficient |
Poor diversification
The 3 months correlation between Lyra and Psyence is 0.68. Overlapping area represents the amount of risk that can be diversified away by holding Lyra Therapeutics and Psyence Biomedical Ltd in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Psyence Biomedical and Lyra Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Lyra Therapeutics are associated (or correlated) with Psyence Biomedical. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Psyence Biomedical has no effect on the direction of Lyra Therapeutics i.e., Lyra Therapeutics and Psyence Biomedical go up and down completely randomly.
Pair Corralation between Lyra Therapeutics and Psyence Biomedical
Given the investment horizon of 90 days Lyra Therapeutics is expected to generate 0.7 times more return on investment than Psyence Biomedical. However, Lyra Therapeutics is 1.42 times less risky than Psyence Biomedical. It trades about -0.05 of its potential returns per unit of risk. Psyence Biomedical Ltd is currently generating about -0.29 per unit of risk. If you would invest 30.00 in Lyra Therapeutics on September 3, 2024 and sell it today you would lose (9.00) from holding Lyra Therapeutics or give up 30.0% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Significant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Lyra Therapeutics vs. Psyence Biomedical Ltd
Performance |
| Timeline |
| Lyra Therapeutics |
| Psyence Biomedical |
Lyra Therapeutics and Psyence Biomedical Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Lyra Therapeutics and Psyence Biomedical
The main advantage of trading using opposite Lyra Therapeutics and Psyence Biomedical positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Lyra Therapeutics position performs unexpectedly, Psyence Biomedical can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Psyence Biomedical will offset losses from the drop in Psyence Biomedical's long position.| Lyra Therapeutics vs. CytomX Therapeutics | Lyra Therapeutics vs. Assembly Biosciences | Lyra Therapeutics vs. Achilles Therapeutics PLC | Lyra Therapeutics vs. Instil Bio |
| Psyence Biomedical vs. DiaMedica Therapeutics | Psyence Biomedical vs. Lyra Therapeutics | Psyence Biomedical vs. Centessa Pharmaceuticals PLC |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Commodity Channel module to use Commodity Channel Index to analyze current equity momentum.
Other Complementary Tools
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
| Content Syndication Quickly integrate customizable finance content to your own investment portal | |
| Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio | |
| Commodity Directory Find actively traded commodities issued by global exchanges | |
| Insider Screener Find insiders across different sectors to evaluate their impact on performance |